United States Pharmaceuticals

60 Degrees Pharmaceuticals Inc (SXTP)

Track

Track

Over the past ninety days, 60 Degrees Pharmaceuticals recorded one insider purchase totaling 10,131.24 USD. CEO Geoffrey S. Dow executed this acquisition. Despite recent stock price declines, these transactions reflect executive confidence following a positive earnings report. No selling activity occurred during this period, maintaining a consistent pattern of accumulation by leadership.
Ticker: SXTP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for 60 Degrees Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.5
DOW GEOFFREY S President and CEO Executive Director
Transaction date
Purchase
Price
253.02
Quantity 30,722 -4.8%
Value US$3,721,707
1.5
DOW GEOFFREY S President and CEO Executive Director
Transaction date
Purchase
Price
391.91
Quantity 75,707 +24.7%
Value US$2,799,551
1.5
DOW GEOFFREY S President and CEO Executive Director
Transaction date
Purchase
Price
209.71
Quantity 67,813 +23.0%
Value US$2,676,703
1.5
DOW GEOFFREY S President and CEO Executive Director
Transaction date
Purchase
Price
0.95
Quantity 9,350 +25.3%
Value US$8,886
1.3
XU CHERYL Non-Executive Director
Transaction date
Purchase
Price
2.90
Quantity 2,000 +14.5%
Value US$5,800
1.3
XU CHERYL Non-Executive Director
Transaction date
Purchase
Price
2.87
Quantity 3,000 +27.7%
Value US$8,610
1.3
XU CHERYL Non-Executive Director
Transaction date
Purchase
Price
1.45
Quantity 2,000 +3.8%
Value US$2,900
1.3
XU CHERYL Non-Executive Director
Transaction date
Purchase
Price
1.52
Quantity 1,500 +3.0%
Value US$2,280
1.3
XU CHERYL Non-Executive Director
Transaction date
Purchase
Price
1.55
Quantity 1,500 +3.1%
Value US$2,325
1.3
XU CHERYL Non-Executive Director
Transaction date
Purchase
Price
1.58
Quantity 1,500 +3.2%
Value US$2,370
1.3
XU CHERYL Non-Executive Director
Transaction date
Purchase
Price
1.60
Quantity 1,500 +3.3%
Value US$2,400
1.3
XU CHERYL Non-Executive Director
Transaction date
Purchase
Price
1.80
Quantity 2,500 +5.7%
Value US$4,500
1.3
XU CHERYL Non-Executive Director
Transaction date
Purchase
Price
1.85
Quantity 2,500 +6.1%
Value US$4,625
1.5
DOW GEOFFREY S President and CEO Executive Director
Transaction date
Purchase
Price
1.27
Quantity 35,823 +61.0%
Value US$45,563
1.5
DOW GEOFFREY S President and CEO Executive Director
Transaction date
Purchase
Price
1.20
Quantity 20,579 +53.9%
Value US$24,672
1.5
DOW GEOFFREY S President and CEO Executive Director
Transaction date
Purchase
Price
1.11
Quantity 17,549 +85.1%
Value US$19,520
1.5
DOW GEOFFREY S President and CEO Executive Director
Transaction date
Purchase
Price
0.91
Quantity 3,500 +20.4%
Value US$3,195
1.5
DOW GEOFFREY S President and CEO Executive Director
Transaction date
Purchase
Price
0.92
Quantity 1,000 +6.2%
Value US$924
1.5
DOW GEOFFREY S President and CEO Executive Director
Transaction date
Purchase
Price
0.90
Quantity 2,500 +18.3%
Value US$2,248
1.3
XU CHERYL Non-Executive Director
Transaction date
Purchase
Price
1.70
Quantity 5,000 +13.9%
Value US$8,500
1.3
XU CHERYL Non-Executive Director
Transaction date
Purchase
Price
0.38
Quantity 200,000 +88.9%
Value US$75,000
1.5
DOW GEOFFREY S President and CEO Executive Director
Transaction date
Purchase
Price
0.38
Quantity 25,974 +3.8%
Value US$9,740
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-12 B Purchase
1.5
DOW GEOFFREY S

President and CEO

Executive Director
30,722 -4.8%
253.02
US$3,721,707 		30,722 -4.8% 253.02 US$3,721,707
2025-12-16 2025-12-15 B Purchase
1.5
DOW GEOFFREY S

President and CEO

Executive Director
75,707 +24.7%
391.91
US$2,799,551 		75,707 +24.7% 391.91 US$2,799,551
2025-12-12 2025-12-11 B Purchase
1.5
DOW GEOFFREY S

President and CEO

Executive Director
67,813 +23.0%
209.71
US$2,676,703 		67,813 +23.0% 209.71 US$2,676,703
2025-12-12 2025-12-10 B Purchase
1.5
DOW GEOFFREY S

President and CEO

Executive Director
9,350 +25.3%
0.95
US$8,886 		9,350 +25.3% 0.95 US$8,886
2025-06-05 2025-06-03 B Purchase
1.3
XU CHERYL
Non-Executive Director
2,000 +14.5%
2.90
US$5,800 		2,000 +14.5% 2.90 US$5,800
2025-06-05 2025-06-03 B Purchase
1.3
XU CHERYL
Non-Executive Director
3,000 +27.7%
2.87
US$8,610 		3,000 +27.7% 2.87 US$8,610
2024-12-18 2024-12-16 B Purchase
1.3
XU CHERYL
Non-Executive Director
2,000 +3.8%
1.45
US$2,900 		2,000 +3.8% 1.45 US$2,900
2024-12-18 2024-12-13 B Purchase
1.3
XU CHERYL
Non-Executive Director
1,500 +3.0%
1.52
US$2,280 		1,500 +3.0% 1.52 US$2,280
2024-12-18 2024-12-13 B Purchase
1.3
XU CHERYL
Non-Executive Director
1,500 +3.1%
1.55
US$2,325 		1,500 +3.1% 1.55 US$2,325
2024-12-18 2024-12-13 B Purchase
1.3
XU CHERYL
Non-Executive Director
1,500 +3.2%
1.58
US$2,370 		1,500 +3.2% 1.58 US$2,370
2024-12-18 2024-12-13 B Purchase
1.3
XU CHERYL
Non-Executive Director
1,500 +3.3%
1.60
US$2,400 		1,500 +3.3% 1.60 US$2,400
2024-12-18 2024-12-12 B Purchase
1.3
XU CHERYL
Non-Executive Director
2,500 +5.7%
1.80
US$4,500 		2,500 +5.7% 1.80 US$4,500
2024-12-18 2024-12-12 B Purchase
1.3
XU CHERYL
Non-Executive Director
2,500 +6.1%
1.85
US$4,625 		2,500 +6.1% 1.85 US$4,625
2024-12-09 2024-12-09 B Purchase
1.5
DOW GEOFFREY S

President and CEO

Executive Director
35,823 +61.0%
1.27
US$45,563 		35,823 +61.0% 1.27 US$45,563
2024-12-09 2024-12-06 B Purchase
1.5
DOW GEOFFREY S

President and CEO

Executive Director
20,579 +53.9%
1.20
US$24,672 		20,579 +53.9% 1.20 US$24,672
2024-12-09 2024-12-05 B Purchase
1.5
DOW GEOFFREY S

President and CEO

Executive Director
17,549 +85.1%
1.11
US$19,520 		17,549 +85.1% 1.11 US$19,520
2024-11-21 2024-11-21 B Purchase
1.5
DOW GEOFFREY S

President and CEO

Executive Director
3,500 +20.4%
0.91
US$3,195 		3,500 +20.4% 0.91 US$3,195
2024-11-21 2024-11-20 B Purchase
1.5
DOW GEOFFREY S

President and CEO

Executive Director
1,000 +6.2%
0.92
US$924 		1,000 +6.2% 0.92 US$924
2024-11-21 2024-11-19 B Purchase
1.5
DOW GEOFFREY S

President and CEO

Executive Director
2,500 +18.3%
0.90
US$2,248 		2,500 +18.3% 0.90 US$2,248
2024-09-11 2024-08-27 B Purchase
1.3
XU CHERYL
Non-Executive Director
5,000 +13.9%
1.70
US$8,500 		5,000 +13.9% 1.70 US$8,500
2024-02-02 2024-01-31 B Purchase
1.3
XU CHERYL
Non-Executive Director
200,000 +88.9%
0.38
US$75,000 		200,000 +88.9% 0.38 US$75,000
2024-02-02 2024-01-31 B Purchase
1.5
DOW GEOFFREY S

President and CEO

Executive Director
25,974 +3.8%
0.38
US$9,740 		25,974 +3.8% 0.38 US$9,740
Explore more

More insider trading research around 60 Degrees Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America